# Vitaflo International, Ltd clinical trials: 23 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 23 trials with Vitaflo International, Ltd as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Vitaflo International, Ltd: 23 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/vitaflo-international-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 16, 2023 | NCT05995717 | Evaluation of PKU UP | Vitaflo International, Ltd | Not applicable | Completed | PKU | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05995717) |
| October 27, 2021 | NCT05096988 | Evaluation of PKU Sphere Liquid | Vitaflo International, Ltd | Not applicable | Completed | Phenylketonurias | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05096988) |
| September 21, 2021 | NCT05051657 | Evaluation of the Express Plus Range | Vitaflo International, Ltd | Not applicable | Completed | Phenylketonurias, PKU, Homocystinuria, Maple Syrup Urine Disease, Hereditary Tyrosinemia, Glutaric Acidemia I | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05051657) |
| May 24, 2021 | NCT04898829 | Evaluation of PKU Explore France | Vitaflo International, Ltd | Not applicable | Completed | Phenylketonurias | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04898829) |
| February 21, 2021 | NCT04761588 | Evaluation of TYR Sphere in France | Vitaflo International, Ltd | Not applicable | Completed | Tyrosinemia, AKU | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04761588) |
| December 22, 2020 | NCT04679467 | Evaluation of PKU Sphere in Italy | Vitaflo International, Ltd | Not applicable | Completed | Phenylketonurias, PKU | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04679467) |
| December 17, 2020 | NCT04672226 | Evaluation of PDE MAX | Vitaflo International, Ltd | Not applicable | Completed | Pyridoxine Dependant Epilepsy | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04672226) |
| May 22, 2020 | NCT04399954 | Evaluation of Ketoflo | Vitaflo International, Ltd | Not applicable | Completed | Epilepsy Intractable, Glucose Transporter Type 1 Deficiency Syndrome, Ketogenic Dieting | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04399954) |
| January 13, 2020 | NCT04224142 | Evaluation of PKU Sphere in Maternal PKU | Vitaflo International, Ltd | Observational | Completed | Maternal Phenylketonuria | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04224142) |
| December 12, 2019 | NCT04196959 | Evaluation of TYR Sphere | Vitaflo International, Ltd | Not applicable | Completed | Tyrosinemias, Alkaptonuria, Tyrosinemia, Type I, Tyrosinemia, Type II, Tyrosinemia, Type III | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04196959) |
| September 3, 2019 | NCT04076176 | The Effects of CGMP in Children and Adults With PKU | Vitaflo International, Ltd | Not applicable | Completed | Phenylketonurias | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04076176) |
| December 11, 2018 | NCT03771391 | A 16 Week Study Evaluating the Introduction of a GMP Based Protein Substitute in Participants With PKU | Vitaflo International, Ltd | Not applicable | Completed | Phenylketonurias | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03771391) |
| July 27, 2018 | NCT03602937 | Evaluation of Renastep | Vitaflo International, Ltd | Not applicable | Completed | Chronic Kidney Diseases, Renal Disease | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03602937) |
| February 5, 2018 | NCT03419819 | Evaluation of PKU Sphere | Vitaflo International, Ltd | Not applicable | Completed | Phenylketonurias | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03419819) |
| June 28, 2017 | NCT03202108 | Evaluation of Krio in Children and Adults With Epilepsy | Vitaflo International, Ltd | Not applicable | Withdrawn | Ketogenic Dieting, Epilepsy, Glucose Transporter Type 1 Deficiency Syndrome | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03202108) |
| May 30, 2017 | NCT03168399 | Evaluation of PKU Explore | Vitaflo International, Ltd | Not applicable | Completed | Phenylketonuria, Inborn Errors of Metabolism | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03168399) |
| February 23, 2017 | NCT03058848 | Evaluation of PKU Start | Vitaflo International, Ltd | Not applicable | Completed | Phenylketonuria, Inborn Errors of Metabolism | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03058848) |
| September 26, 2016 | NCT02915211 | Evaluation of Keyo in Children With Epilepsy | Vitaflo International, Ltd | Not applicable | Completed | Intractable Epilepsy, Glucose Transporter Type 1 Deficiency Syndrome, Ketogenic Dieting | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02915211) |
| July 7, 2016 | NCT02825784 | A Multicenter Study to Evaluate the Nutritional Suitability of Renastart | Vitaflo International, Ltd | Not applicable | Completed | Chronic Kidney Disease, Hyperkalemia | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02825784) |
| July 7, 2016 | NCT02825758 | Evaluation of ZestiVits in Children and Adults on a Ketogenic or Restricted Therapeutic Diet | Vitaflo International, Ltd | Not applicable | Completed | Deficiency of Micronutrients | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02825758) |
| July 7, 2016 | NCT02825745 | Use of Betashot in Children and Adults With Epilepsy | Vitaflo International, Ltd | Not applicable | Completed | Nervous System Disorder | 77 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02825745) |
| December 17, 2014 | NCT02318966 | Glycosade v UCCS in the Dietary Management of Hepatic GSD | Vitaflo International, Ltd | Not applicable | Completed | Glycogen Storage Disease | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02318966) |
| September 1, 2014 | NCT02229318 | A Taste and Acceptance Study of FruitiVits in Children Aged 4-8 Years Following a Ketogenic Diet. | Vitaflo International, Ltd | Not applicable | Completed | Seizure Disorders | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02229318) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 22 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 22 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Phenylketonurias | 11 |
| Epilepsy | 3 |
| Glut1 Deficiency Syndrome | 3 |
| Tyrosinemias | 3 |
| Metabolism, Inborn Errors | 2 |
| Renal Insufficiency, Chronic | 2 |
| Drug Resistant Epilepsy | 2 |
| Alkaptonuria | 2 |
| Phenylketonuria, Maternal | 1 |
| Hyperkalemia | 1 |
| Glycogen Storage Disease | 1 |
| Kidney Diseases | 1 |
| Nervous System Diseases | 1 |
| Homocystinuria | 1 |
| Maple Syrup Urine Disease | 1 |
| Glutaric Acidemia I | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Elevator companies in the United States](https://specstream.ai/data/businesses/elevator-companies/united-states)
- [Water delivery companies in the United States](https://specstream.ai/data/businesses/water-delivery-companies/united-states)
- [Medical transportation companies in the United States](https://specstream.ai/data/businesses/medical-transportation-companies/united-states)
- [Cosmetic dentistry practices in the United States](https://specstream.ai/data/businesses/cosmetic-dentistry-practices/united-states)
- [Tax law firms in the United States](https://specstream.ai/data/businesses/tax-law-firms/united-states)
- [IT consultants in the United States](https://specstream.ai/data/businesses/it-consultants/united-states)
